Margo R. Roberts, Chief Scientific Officer at Kite Pharma, Inc. (KITE), sold 6,145 shares at $62.62 ($385K) on 2015-10-15, disclosed to the SEC on 2015-10-19.
Scheduled sale ($385k) by Chief Scientific Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $60.08 | 361 | $22K | 5.6% |
| 2 | $61.79 | 1,300 | $80K | 20.9% |
| 3 | $62.62 | 2,800 | $175K | 45.6% |
| 4 | $63.60 | 1,600 | $102K | 26.5% |
| 5 | $64.25 | 84 | $5K | 1.4% |
| Total | $62.57 avg | 6,145 |
| $385K |
| 100% |
| Filing → |
| KITE | SELL | 2016-02-16 | $1.2M | — | Filing → |
| KITE | SELL | 2016-01-19 | $339K | — | Filing → |
| KITE | SELL | 2015-12-17 | $392K | — | Filing → |